Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Case-controlled Randomized Study of Human Reproductive Tract Active Lactobacillus in Adjuvant Treatment of Recurrent Vulvovaginal Candidiasis.

NCT04699240 is registered in ClinicalTrials.gov with Peking University Shenzhen Hospital as lead sponsor.

NCT NCT04699240
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04699240 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Case-controlled Randomized Study of Human Reproductive Tract Active Lactobacillus in Adjuvant Treatment of Recurrent Vulvovaginal Candidiasis.
Lead sponsor
Peking University Shenzhen Hospital
Phase
Phase 4
Overall status
Completed
Start date
July 1, 2020
Completion date
December 30, 2023
Enrollment
140 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

recurrent vulvovaginal candidiasis